Valuation (12%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -9.33 | 22.06 |
PEG Ratio (TTM) | -0.40 | 0.33 |
P/S Ratio (TTM) | 6.70 | 1.22 |
P/B Ratio (TTM) | 2.34 | 4.63 |
P/FCF Ratio (TTM) | -15.37 | 25.30 |
Price to 5YR AVG Earnings Ratio | N/A | 19.16 |
Price to 5YR AVG FCF Ratio | N/A | 33.42 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -19.30% | 6.82% |
ROE (TTM) | -23.78% | 23.17% |
Net Profit Margin (TTM) | -71.11% | 5.63% |
ROIC 5YR AVG | N/A | 23.78% |
Growth (30%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 12.51% | -766.54% | N/A |
Revenue | 4.94% | 36.20% | N/A |
Net Income | 12.02% | -77.16% | N/A |
Cash Flow | -23.57% | -59.06% | N/A |
Health (33%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 2.90 | 1.22 |
Quick Ratio (TTM) | 2.90 | 1.20 |
D/E Ratio (TTM) | N/A | 0.85 |
Interest Coverage (TTM) | -76.67 | 19.16 |
Piotroski F-Score | 2 | 6 |
Altman Z-Score | 1.50 | 3.75 |
LTL to 5YR AVG FCF | N/A | 8.82 |
Shares Outstanding Growth 5YR AVG | N/A | -0.79% |